Sažetak epizode
Dr. Rajesh Rao interviews Dr. Katherine E. Talcott on her Ophthalmology Retina article "Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors." They discuss the study which aimed to characterize the associations between systemic TKIs and the risks of retinal artery occlusion and retinal vein occlusion. Jeong H, et al. Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors. Ophthalmology Retina, 2026; Volume 10, Issue 7, 734-744. The 2026–2027 BCSC Section 12: Retina and Vitreous features expanded updates on AMD and recently approved intravitreal injections and gene therapies, updated hydroxychloroquine guidance, 15 new surgical and diagnostic videos, and two interactive case studies. Order Section 12 today at www.aao.org/BCSC AAO 2026 may be over in New Orleans, but the learning continues through March 2027. Access more than 300 expert-led sessions on your schedule, from wherever you are. Experience the discussions shaping ophthalmology…
Dr. Rajesh Rao interviews Dr. Katherine E. Talcott on her Ophthalmology Retina article "Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors." They discuss the study which aimed to characterize the associations between systemic TKIs and the risks of retinal artery occlusion and retinal vein occlusion. Jeong H, et al. Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors. Ophthalmology Retina, 2026; Volume 10, Issue 7, 734-744. The 2026–2027 BCSC Section 12: Retina and Vitreous features expanded updates on AMD and recently approved intravitreal injections and gene therapies, updated hydroxychloroquine guidance, 15 new surgical and diagnostic videos, and two interactive case studies. Order Section 12 today at www.aao.org/BCSC AAO 2026 may be over in New Orleans, but the learning continues through March 2027. Access more than 300 expert-led sessions on your schedule, from wherever you are. Experience the discussions shaping ophthalmology…
Epizode
Risks of Retinal Vascular Occlusions with Tyrosine Kinase Inhibitors
SlušanoDr. Rajesh Rao interviews Dr. Katherine E. Talcott on her Ophthalmology Retina article "Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors." They discuss the study which aimed to characterize the associations between systemic TKIs and the risks of retinal artery occlusion and retinal vein occlusion. Jeong H, et al. Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors. Ophthalmology Retina, 2026; Volume 10, Issue 7, 734-744. The 2026–2027 BCSC Section 12: Retina and Vitreous features expanded updates on AMD and recently approved intravitreal injections and gene therapies, updated hydroxychloroquine guidance, 15 new surgical and diagnostic videos, and two interactive case studies. Order Section 12 today at www.aao.org/BCSC AAO 2026 may be over in New Orleans, but the learning continues through March 2027. Access more than 300 expert-led sessions on your schedule, from wherever you are. Experience the discussions shaping ophthalmology…
Depression and Anxiety After Topical Carbonic Anhydrase Inhibitors
SlušanoDr. Drew Carey speaks with Dr. Abdelrahman Elhusseiny on his study of the association between topical carbonic anhydrase inhibitor use and the development of depression and anxiety disorders in patients with glaucoma. From his Ophthalmology Science article, "Depression and Anxiety After Topical Carbonic Anhydrase Inhibitors." Elhusseiny A, et al. Depression and Anxiety After Topical Carbonic Anhydrase Inhibitors. Ophthalmology Science, Volume 6, Issue 4. Ophthalmology journal events at AAO 2026: Peer Review Masterclass: A Practical Workshop for Journal Authors and Reviewers: Become a peer reviewer for the Academy's Ophthalmology journal, the leading journal in the field, and its companion journals, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science. Dr. Aaki Shukla and Dr. Benjamin Xu, highly experienced reviewers and authors for various journals, will lead this free interactive workshop. Sponsored by Elsevier. Saturday October 10 at 10:30am CT in the Academy Theater. The Year in…
Lacquer Crack Visible Light OCT
SlušanoDr. Edmund Tsui interviews a team of researchers from New York University Grossman School of Medicine: Galen Hu, MD, Vivek Srinivasan, PhD, and Nitish Mehta, MD. The team discusses their case study which applied ultra-high resolution visible light optical coherence tomography towards acute and chronic lacquer cracks in a patient with pathologic myopia. From their Ophthalmology Science article, "Insights on Acute and Chronic Lacquer Cracks as Imaged with Visible Light OCT." Hu G, et al. Insights on Acute and Chronic Lacquer Cracks as Imaged with Visible Light OCT. Ophthalmology Science, 2026; Volume 6, Issue 4. AAO 2026 is almost here! Join the international ophthalmology community October 9-12 for expert education, the latest clinical insights and the conversations shaping the future of ophthalmology. Can't make it to New Orleans? Bring AAO 2026 to you with the virtual meeting. Access live and recorded education from wherever you are, anywhere in the world. Register at www.aao.org/RegNow Ophthalmology…
Fuchs Endothelial Corneal Dystrophy and Cardiometabolic Comorbidities
SlušanoDr. Emily is Schehlein is joined by Dr. Clara C. Chan and medical student Andrew Mihalache to discuss their report that showed individuals with Fuchs' endothelial corneal dystrophy exhibited a higher burden of cardiometabolic disease than matched controls. From their Ophthalmology article, "Fuchs' Endothelial Corneal Dystrophy and Cardiometabolic Comorbidities." Mihalache A, et al. Fuchs' Endothelial Corneal Dystrophy and Cardiometabolic Comorbidities. Ophthalmology, 2026; Volume 133, Issue 6, 777-779. Ophthalmology journal events at AAO 2026: Peer Review Masterclass: A Practical Workshop for Journal Authors and Reviewers: Become a peer reviewer for the Academy's Ophthalmology journal, the leading journal in the field, and its companion journals, Ophthalmology Retina, Ophthalmology Glaucoma, and Ophthalmology Science. Dr. Aaki Shukla and Dr. Benjamin Xu, highly experienced reviewers and authors for various journals, will lead this free interactive workshop. Sponsored by Elsevier. Saturday October 10 at…
Cardiovascular Risk and Eye Health
SlušanoDr. Rukhsana Mirza is joined Dr. Dr. Anne Coleman. They discuss Dr. Coleman's study evaluating whether the Pooled Cohort Equations cardiovascular risk scores are associated with the future development and can predict future development of age-related macular degeneration, glaucoma, diabetic retinopathy, retinal vein occlusion, and hypertensive retinopathy. From her Ophthalmology article, "Cardiovascular Risk and Eye Health: A Cohort Study of the Pooled Cohort Equations and Ocular Disease Incidence." Cardiovascular Risk and Eye Health: A Cohort Study of the Pooled Cohort Equations and Ocular Disease Incidence. Sun D, et al. Ophthalmology, Volume 133, Issue 5, 645-653. The 2026–2027 BCSC Section 12: Retina and Vitreous features expanded updates on AMD and recently approved intravitreal injections and gene therapies, updated hydroxychloroquine guidance, 15 new surgical and diagnostic videos, and two interactive case studies. Order Section 12 today at www.aao.org/BCSC Join colleagues from around the world at AAO…